Walter Kalmans

Walter Kalmans is a seasoned pharmaceutical executive highly specialized in the field of specialty drugs, particularly in oncology.

He holds a Master's in Business Administration in Marketing from Duke University's The Fuqua School of Business, a Bachelor's in Science in Finance from The Wharton School, and a Bachelor's in Arts in Molecular Biology and Finance from the University of Pennsylvania.

Walter Kalmans has a diverse educational background, having studied at St. John's School and obtained additional Bachelor of Science and MBA degrees at the University of Pennsylvania and Duke University respectively.

Throughout his career, Walter has held significant leadership roles in various organizations, including being the President of Lontra Ventures and previously served as the President and CEO of Cb2 Pharma, Vice President of Business Development at Mckesson, Director of Business Development at Bristol-Myers Squibb, Vice President of Business Development at OTN, Director of Marketing at Whisperwire, Director of Product Marketing at Vignette, and Director of Marketing and Business Development at BD.

Walter Kalmans also has prior experience working as a Summer Associate at The Walt Disney Company, a Senior Consultant at Accenture, and an Associate at Strategy&.

His wealth of experience in the pharmaceutical industry coupled with his diverse educational background makes Walter Kalmans a highly sought-after professional in the field.

Walter's expertise and leadership skills are evident through his significant roles in various prominent organizations, showcasing his ability to drive business growth and development effectively.